After this morning's 4.0% surge to $149.62 per share, Datadog might just keep moving past its target price of $152.45. With an average analyst rating of buy, and target prices from $128.0 to $230.0, ...

Standing out among the Street's worst performers today is Banco Santander, a commercial banking company whose shares slumped -4.0% to a price of $4.55, 28.91% below its average analyst target price of ...

Cameco Corporation provides uranium for the generation of electricity. The company is now trading -29.19% away from its average analyst target price of $84.71 per share. The 5 analysts following the ...

Another way to gauge the sentiment on Affirm is to look at the percentage of institutions that are invested in the stock. In this case, 78.6% of the shares are held by pension, mutual, and hedge funds ...

For Copart, average sales revenue over the last 5 years has been $4.09 Billion, so in the context of the Graham analysis the stock has impressive sales revenue. Originally the threshold was $100 ...

Deckers Outdoor trades -0.07% away from its average analyst target price of $188.3 per share. The 21 analysts following the stock have set target prices ranging from $115.0 to $232.0, and on average ...

In the 10-K report, Maximus provided a detailed analysis of its financial condition and results of operations. The company reported a significant increase in revenue for the fiscal year ended ...

BGC Group, Inc. (NASDAQ: BGC) has announced that its Chairman and Chief Executive Officer Howard W. Lutnick has been nominated by President Donald J. Trump to serve as the 41st U.S. Secretary of ...

As of September 30, 2024, the company’s assets totaled $17.09 billion.

QuidelOrtho Corporation, a global provider of in vitro diagnostics technologies, recently announced the pricing of a secondary offering of common stock by Carlyle Partners VI Cayman Holdings, L.P. The ...

Korro Bio, Inc. (Korro) (NASDAQ: KRRO) has received approval from the Australian Bellberry Human Research Ethics Committee (HREC) and clearance from the Australian Therapeutic Goods Administration ...

Kyndryl Holdings, Inc. has made a significant announcement, revealing a $300 million share repurchase program. This move reflects the company's confidence in its business and outlook for profitable ...